[
  {
    "ts": null,
    "headline": "Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the Blue Chip Stocks to Buy with the Lowest PE Ratios. On September 8, Amgen Inc. (NASDAQ:AMGN), along with Kyowa Kirin preliminary top-line results from the ASCEND study of Rocatinlimab in moderate to severe atopic dermatitis. Rocatinlimab is an experimental T-cell therapy targeting the OX40 receptor, which aims to rebalance […]",
    "url": "https://finnhub.io/api/news?id=89a558e6abf48ea35e5660eda7258ed94631bceab74f6773e72e200ef70339b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757612951,
      "headline": "Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab",
      "id": 136704098,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the Blue Chip Stocks to Buy with the Lowest PE Ratios. On September 8, Amgen Inc. (NASDAQ:AMGN), along with Kyowa Kirin preliminary top-line results from the ASCEND study of Rocatinlimab in moderate to severe atopic dermatitis. Rocatinlimab is an experimental T-cell therapy targeting the OX40 receptor, which aims to rebalance […]",
      "url": "https://finnhub.io/api/news?id=89a558e6abf48ea35e5660eda7258ed94631bceab74f6773e72e200ef70339b5"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=95cdbf7e42a910cad6d514c344349f34f3ceb4401c9c9e1a0e4cd28ee586afda",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757608560,
      "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "id": 136714848,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=95cdbf7e42a910cad6d514c344349f34f3ceb4401c9c9e1a0e4cd28ee586afda"
    }
  }
]